Status:
COMPLETED
Patient-centered Communication About Healthy Weight in Early Breast Cancer
Lead Sponsor:
UNC Lineberger Comprehensive Cancer Center
Collaborating Sponsors:
American Cancer Society, Inc.
Pfizer
Conditions:
Breast Cancer
Eligibility:
All Genders
21-99 years
Brief Summary
Comorbidities in breast cancer survival account for 49% of overall survival difference between black and white women. Many obesity-related comorbidities disproportionately affect black women, therefor...
Detailed Description
The overall goal of this research is to collect essential input for the future development of a quality improvement intervention to foster "Patient-Center Communication about Healthy Weigh in clinical...
Eligibility Criteria
Inclusion
- Inclusion Criteria for Breast Cancer Cohort:
- Age 21 or older
- Diagnosed with early breast cancer, Stages I-III
- Completed primary treatment (Surgery, chemotherapy, radiation) within past 2 years
- Body mass Index of equal or greater than 30
- Exclusion Criteria:
- Cannot understand and speak English
- INclusion Criteria for Oncology provider cohort:
- Breast cancer oncology provider in North Carolina with MD/DO/PA/NP/RN
- associated with community-based practices
Exclusion
Key Trial Info
Start Date :
June 15 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 29 2020
Estimated Enrollment :
39 Patients enrolled
Trial Details
Trial ID
NCT04504201
Start Date
June 15 2020
End Date
September 29 2020
Last Update
July 29 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of North Carolina at Chapel Hill
Chapel Hill, North Carolina, United States, 27599